Our study demonstrated that the primary cause for the reduction of PD-1+ CD8 T cells during TLP is the absolute decrease in the number of CD8 T cells within the TDLNs, where clonal amplification of CD8 T cells responding to tumor antigens is initiated. The gene discussed is CD8A; the disease is neoplasm.